The elicitation of contact sensitivity (CS) to local skin challenge with the hapten trinitrophenyl (TNP) chloride requires an early process that is necessary for local recruitment of CS-effector T cells. This is called CS initiation and is due to the B-1 subset of B cells activated at immunization to produce circulating IgM Ab. At challenge, the IgM binds hapten Ag in a complex that locally activates C to generate C5a that aids in T cell recruitment. In this study, we present evidence that CS initiation is indeed mediated by C-activating classic IgM anti-TNP pentamer. We further demonstrate the involvement of IgM subunits derived either from hybridomas or from lymphoid cells of actively immunized mice. Thus, reduced and alkylated anti-TNP IgM also initiates CS, likely due to generated H chain-L chain dimers, as does a mixture of separated H and L chains that still could weakly bind hapten, but could not activate C. Remarkably, anti-TNP L chains alone mediated CS initiation that was C-independent, but was dependent on mast cells. Thus, B-1 cell-mediated CS initiation required for T cell recruitment is due to activation of C by specific IgM pentamer, and also subunits of IgM, while L chains act via another C-independent but mast cell-dependent pathway.
W e showed previously that the effector arm of delayedtype hypersensitivity responses such as contact sensitivity (CS) 3 has an early CS-initiating component that is required for subsequent local extravascular recruitment of effector T cells that mediate the late classical component (1, 2) . 4 T cells recruited into the tissues are then activated by specific Ag/ MHC complexes expressed on local APC to produce proinflammatory cytokines, such as IFN-␥, to mediate classical late CS (1, 2) . 4 Initiation of the elicitation of CS requires local release of the vasoactive amine serotonin by mast cells and platelets (3, 4) , and also release of the vasoactive cytokine TNF-␣ by mast cells (2) to induce expression of adhesion molecules, such as ICAM-1 and VCAM-1, on the luminal surface of local endothelium (5) . Expressed adhesion molecules likely bind integrins expressed on the surface of circulating activated CS-effector T cells (6, 7) , leading to T cell recruitment into the tissues.
Recently, we studied early steps in the CS initiation process. We found that C activation was required to locally generate C5a to bind C5aRs on mast cells and platelets, causing release of serotonin and TNF-␣ required for T cell recruitment (1, 2, 8) . We established that B cell Abs mediated C activation for CS initiation by demonstrating absent CS ear swelling and local elaboration of IFN-␥ in pan B cell-deficient MT (1) and JH Ϫ/Ϫ4 mice, and in xid mice 4 predominantly deficient in B-1 B cells that make the Cactivating IgM (9) . Elicitation of CS was reconstituted in sensitized xid mice by adoptive transfer of B-1 cells. 4 Because B-1 B cells produce IgM Ab, we tested the ability of anti-trinitrophenyl (TNP) monoclonal IgM Ab to initiate CS in TNP-chloride (TNPCl) sensitized B-1 cell-deficient mice. 4 Two different anti-TNP IgM mAb given i.v. to sensitized xid mice just before challenge reconstituted elicitation of 24 h CS, i.e., IgM Ab restored recruitment of effector T cells. 4 The current study analyzes the forms of IgM that mediate CS initiation and demonstrates involvement of not only pentameric IgM, but also subunits of IgM. Because prior study suggested that an Ag-binding and CS-initiating factor (10 -12) of molecular mass smaller than IgM was involved, we examined the role of IgM subunits. Interestingly, we found that IgM subunits had CS-initiating activity, including dimers of covalently linked H and L chains, and also separated H and L chains. Remarkably, even anti-TNP L chain and recombinant anti-TNP chain both mediated CS initiation. Although prior studies suggested that CS initiation was C-dependent (1, 2, 8) , the chain-mediated effect was not C-dependent, but was mast cell-dependent, as described recently (13) . This likely is due to direct binding to mast cells via a postulated receptor for L chains, enabling subsequent activation by added Ag (13) .
We concluded that IgM pentameric Ab is a major B-1 cell product mediating CS initiation via C activation to generate C5a to activate mast cell and platelet release of vasoactive mediators, leading to T cell recruitment. Additionally, CS initiation also can be mediated by subunits of IgM such as H-L dimers, perhaps via C activation, but L chains act seemingly via direct mast cell activation to initiate CS.
Materials and Methods

Isolation of hybridoma culture-derived IgM by TNP-BSA affinity chromatography
Hybridoma 32.17 producing anti-TNP IgM (provided by J. Fleishman, Washington University, St. Louis, MO) was grown in DMEM with 10% FCS. Culture supernatant (1L) was applied to a 35-ml TNP-BSA Sepharose 4B column preequilibrated at 4°C. Then, the column was washed with PBS (pH 7.2) until OD 280 was Ͻ0.01. Bound proteins were eluted with base (3 ml of 0.2 M Na 2 CO 3 (pH 11)) followed by PBS. OD 280 of eluates was measured by spectrophotometer and IgM H chain quantitated by ELISA. IgM H chain-positive fractions were pooled and dialyzed against PBS at 4°C, and protein concentrations measured by Bradford assay (Bio-Rad, Hercules, CA) using BSA standard.
Preparation of IgM from ascites with anti-H chain affinity chromatography
Anti-TNP IgM was prepared from subclone 13.4-G-8, derived from another hybridoma 13.4 (provided by F. T. Liu, Department of Dermatology, University of California, Davis, CA) by limiting dilution to isolate higher IgM Ab-producing cells. 13.4-G-8 cells were injected i.p. into nude mice and ascites precipitated with 50% saturated NH 4 SO 4 , dialyzed thoroughly against PBS, and centrifuged at 10,000 rpm ϫ 30Ј to remove particles. The enriched IgM fraction was purified via an anti-mouse IgM H chain-linked agarose affinity column (Sigma-Aldrich, St. Louis, MO) equilibrated at 4°C with PBS made with LPS-free water, and then eluted with buffer (Pierce, Rockford, IL).
Superose 6 gel filtration and ELISA quantitation of anti-TNP IgM mAb
Fast protein liquid chromatography (FPLC; Amersham Pharmacia Biotech, Piscataway, NJ) using a Superose 6 HR 10/30 gel filtration column was used for further sizing purification of TNP affinity-purified 32.17 IgM. The column was equilibrated with 0.1 M Tris-HCl (pH 8.0) at 0.2-0.5 ml/min for 3 h. TNP affinity column-purified 32.17 IgM was concentrated by 100 K molecular mass cut-off concentrators (Millipore, Bedford, MA) to 2 mg/ml, and 1 mg IgM applied to the column and proteins were eluted at a flow rate of 0.3 ml/ml using 0.1 mM Tris-HCl (pH 8.0). Fractions (0.5 ml) were collected and assayed for IgM by ELISA vs standard mouse IgM (Calbiochem, La Jolla, CA) by dilution in 0.2 M carbonate buffer (pH 9.0) and coating wells at 37°C for 2 h, followed by blocking nonspecific binding with 3% milk, and then development using goat anti-mouse irrelevant myeloma IgM followed by anti-goat IgG-HRP (Caltag Laboratories, South San Francisco, CA), measuring color development at 450 nm. Peaks with high IgM were pooled for further studies.
Reductive alkylation of IgM to obtain subunits
Anti-TNP IgM (32.17 or 13.4) (1 mg/ml in 150 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA (pH 8)) was reduced strongly with 20 mM DTT or reduced mildly with 0.25 mM DTT for 2 h at 37°C. We determined previously that mild reduction resulted in predominant H-L dimers (i.e., covalently joined H and L chains), and strong reduction resulted in separated H and L chains. Iodoacetamide (40 mM) was added to alkylate the dissociated fragments of IgM, followed by thorough dialysis against PBS. Intact IgM and reductively alkylated fragments were analyzed by SDS-PAGE with 2-15% gradient gels (8 ϫ 7 ϫ 0.75-cm; Daiichi Chemical, Tokyo, Japan) under nonreducing conditions unless otherwise stated. Electrophoresis was conducted at 150 V starting at 25 mA for 1.5 h. Resolved proteins were visualized by staining with Coomassie blue for 1 h and then destaining with 5% acetic acid.
Isolation of TNP-binding IgM subunits from actively TNP-Cl contact-sensitized mice
Thirty CBA/J male mice (6 -8 wk old) were contact sensitized with 150 l of 5% picryl chloride (PCl) (TNP-Cl), and were sacrificed 1 day later. Then, lymph nodes and spleens containing CS-initiating cells were removed and processed to single-cell suspensions (14) . The resulting lymphoid cells were cultured in complete RPMI medium without serum for 48 h at 1.7 ϫ 10 7 cells/ml at 37°C in 5% CO 2 (5 ϫ 10 9 cells in 300 ml). Supernatant was collected by centrifuging the cells and applied to a TNP-BSA Sepharose B column that was washed thoroughly with PBS, and bound proteins were eluted with base (3 ml of 0.2-M Na 2 CO 3 , pH 11), 2-ml fractions collected, and OD 280 eluted peak dialyzed at 4°C with PBS, resulting in protein at 2 mg/ml that was reduced and alkylated as above (14) , and was later injected into 4-day PCl immune xid mice at 100 g per recipient to test for initiation of CS, or analyzed by Western blotting.
Western blotting
For analysis of in vivo-derived anti-TNP binding material, 4 ml of TNP column-purified material was dialyzed against PBS, concentrated with 10,000 molecular mass cut-off concentrators (Millipore), and then was analyzed by Western blotting. Proteins were separated by 12% SDS-PAGE under reducing and nonreducing conditions and transferred onto a nitrocellulose membrane (Bio-Rad) at 30 V overnight at 4°C. The membrane was blocked with 5% milk for 2 h at 25°C followed by staining with goat anti-H or anti-chain Abs (Caltag Laboratories), followed by anti-goat IgG-alkaline phosphatase. Specific bands were developed by using 5-bromo-4-chloro-3-indolyl phosphate one component substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD).
Reconstitution of PCl-sensitized B-1 cell-deficient xid mice by i.v. injection of IgM or subunits
Male 5-to 6-wk-old CBA/J (The Jackson Laboratory, Bar Harbor, ME) and CBA/N-xid mice (Taconic Farms, Germantown, NY) mice were rested at least 1 wk before use and maintained in microisolators according to guidelines of the Animal Care and Use Committee of Yale University School of Medicine (New Haven, CT). Spontaneous C5-deficient DBA/2, C5-normal DBA/1, or mast cell-deficient male WBB6F1/J-Kit w/ Kit w-v mice and ϩ/ϩ congenic wild-type WBB6F1 ϩ/ϩ controls (The Jackson Laboratory) also were used.
Mice were contact sensitized with 150 l of 5% TNP-Cl in absolute ethanol and acetone (4:1) on the shaved chest and abdomen. Four days later, CS responses were elicited by a topical application on both ears with 10 l of 0.4% TNP-Cl in acetone and olive oil (1:1). Thickness of challenged ears was measured with a dial caliper (Ozaki, Tokyo, Japan) or micrometer (Mitutoyo, Tokyo, Japan) before, and at 2 and 24 h after challenge. Increases in ear thickness in groups of 4 -6 mice were expressed as the mean Ϯ SE ϫ 10 Ϫ2 mm. To reconstitute defective elicitation of CS in B-1 cell-deficient CBA/Nxid mice, we i.v. transferred anti-TNP IgM pentamer, or its subunit H-L dimer, or fully separated mixed H and L chains. Reconstitution of CS with anti-TNP L chains in pan B cell-deficient MT mice was performed similarly. Prospective recipient xid or MT mice were sensitized with TNP-Cl and 4 days later, after i.v. transfer of IgM or subunits or L chains, were ear challenged with TNP-Cl. One group of sensitized MT mice was injected i.v. with 5 g TNP-specific L chain 30 min before challenge. In some experiments, component C5 was depleted by injection of anti-C5 mAb vs an isotype-matched control (Alexion, Cheshire, CT), just 1 h before ear challenge (1).
In vitro hapten binding and C binding by IgM pentamer and subunits
To investigate the hapten-binding capacity of IgM subunits, anti-sialylLeX carbohydrate IgM mAb was used so that flow cytometry assay could be used, and was prepared from FH-6 hybridoma (American Type Culture Collection (ATCC), Rockville, MD), similar to 32.17 IgM purification. Reductive alkylation described above generated H-L dimers and separated H and L chains. HL-60 human leukemia cells, which naturally highly express surface sialyl-LeX determinants, were incubated for 45 min with dilutions of anti-sialyl-LeX monoclonal IgM pentamer, H-L dimer, or separated H and L chains in 4°C PBS containing 2% FBS and 0.05% NaN 3 . Biotin-conjugated anti-Ab (Cappel, Aurora, OH), and then streptavidin-PE (BD PharMingen, San Diego, CA) were added sequentially to detect sialyl-LeX-specific IgM and subunits bound on the surface of HL-60 cells using flow cytometry.
In a second direct hapten-binding assay, ELISA plates were coated either with TNP-BSA or BSA (50 l, 100 g/ml) overnight at 4°C, followed by blocking with 1% BSA in PBS at 25°C for 2 h, and then 100 l IgM or subunits were added for 1 h at 25°C. Then, biotinylated anti-(Cappel) followed by 1/3000 diluted HRP-conjugated streptavidin (Vector Laboratories, Burlingame, CA) were added to detect bound IgM or subunits. Tetramethylbenzidine peroxidase substrate and tetramethylbenzidine one component stop solution (Kirkegaard & Perry Laboratories) were used for color development followed by measurement at 450 nm.
For assay of C binding after attaching anti-sialyl-LeX IgM mAb to the surface of highly sialyl-LeX expressing HL-60 cells (5 ϫ 10 6 ) were incubated with IgM or subunits at 0°C for 45 min, washed once with gelatin Veronal buffer 2ϩ (0.1% gelatin, 0.15 mM CaCl 2 , 0.5 mM MgCl 2 ), and fresh normal human serum (2.5%) diluted with gelatin Veronal buffer 2ϩ added for 60 min at 37°C as a source of C. Human C3b deposited on the cell surface was detected by flow cytometry using 2 g/l biotinylated goat IgG anti-human C3b (Cappel), followed by PE-conjugated streptavidin (1/400; BD PharMingen).
Isolation of TNP-specific L chain and recombinant L chain
TNP-specific IgG1 chain-containing mAb was isolated from culture supernatant of murine 1B7-11 hybridoma (ATCC) by affinity purification using protein G-Sepharose (Amersham Pharmacia Biotech) (13) . Purified IgG was reduced with 200 mM 2-ME in 5 mM Tris-HCl, 150 mM NaCl, pH 8.0 (60 min, 37°C), and subsequently alkylated with 300 mM iodoacetamide (3 min on ice). The treated sample was concentrated (Centriprep-10; Millipore) and immediately subjected to high performance gel filtration chromatography (Superdex-200; Amersham Pharmacia Biotech). Ig H and L chains were separated in 6 M guanidine (pH 6.5) using a flow rate of 0.5 ml/min. Fractions containing Ig chains were pooled and were dialyzed extensively against PBS followed by batch treatment with protein-G Sepharose beads to further exclude contamination with H chain. Purity of the Ig H and chain fractions was verified by reducing and nonreducing SDS-PAGE followed by Coomassie blue or silver staining.
Recombinant Ig L chain was produced by PCR amplification of the cDNA fragment coding for VL-CL from TNP-specific IgG1-producing hybridoma 1B7-11 (ATCC). The amplified product was ligated into a pGEX vector and the recombinant product was expressed in Escherichia coli using standard molecular biological techniques. Recombinant GST-fusion proteins were purified using glutathione-Sepharose affinity chromatography (13) .
L chain reconstitution of CS in MT mice
CS reactions were studied in pan B cell-deficient 6-to 12-wk-old female C57BL/6 MT mice (n ϭ 4), kindly provided by Dr. J. Louis (University of Lausanne, Lausanne, Switzerland). Experiments were performed as described previously (15) . Briefly, mice were sensitized on one ear with 2% TNP-Cl (PCl; 20 l of a 4:1 acetone/olive oil solution), and 7 days later were challenged with 1% TNP-Cl (PCl; 20 l in 1:9 acetone/olive oil) applied on the previously untreated ear. Specific ear swelling was determined by measuring ear thickness before and 24 h after the PCl challenge using a micrometer (Oditest; Kroeplin, Schlüchtern, Germany). Nonspecific ear swelling caused by 1% TNP-Cl (PCl) challenge in naive animals (irritant reaction) was subtracted from the results of the experimental groups. One group of MT mice received one i.v. injection of 5.0 g TNP-specific L chains 0.5 h before the TNP-Cl (PCl) ear challenge, and a control group received PBS injection i.v.
Statistics
Differences in values of ear swelling for various experimental groups were examined for significance using the two-tailed students t test, and in addition by analysis of variance by two-tailed ANOVA. Data are presented as the mean response Ϯ SE, and p Ͻ 0.05 was taken as the level of significance.
Results
Anti-TNP IgM pentamer reconstitutes CS in B-1 cell-deficient xid mice
We showed previously that elicitation of CS with TNP-Cl was impaired in pan B cell-deficient MT (1) and JH Ϫ/Ϫ mice 4 as well as in CBA/N-xid mice with dominant B-1 B cell deficiency. 4 Reconstitution with B-1 cells from TNP-immune donors restored the impaired CS. 4 Because B-1 cells mainly produce IgM (9), we tested that B-1 cell-derived anti-hapten IgM Ab was involved and found that hybridoma-derived anti-TNP IgM alone could reconstitute CS in previously sensitized B-1 cell-deficient xid mice. 4 Therefore, we concluded that reconstitution of CS with immune B-1 cells likely was due to their production of anti-hapten IgM Ab.
To test whether IgM pentamer was responsible, we further purified anti-TNP IgM mAb 32.17 via a combination of a TNP hapten affinity column followed by FPLC size exclusion chromatography. The FPLC peaks "I" through "IV" (Fig. 1a) were analyzed by nonreducing SDS-PAGE (Fig. 1b) . The FPLC excluded void fraction of high molecular mass material eluted as peak I and contained 98% pure IgM pentamer (900 kDa; Fig. 1b, lane B) . In contrast, the starting hybridoma-derived IgM eluted from the anti-TNP affinity column (Fig. 1b, lane A) contained predominant IgM pentamer that just entered the gel above the 670-kDa marker, and also smaller IgM subunit bands, possibly representing joined H-H dimer (160 kDa), H-L 2 trimer (130 kDa), and some H-L dimer. The subsequent FPLC peak II (Fig. 1a ) may predominately represent H-L 2 trimer (Fig. 1b Using an IgM H chain-specific ELISA, we confirmed that the 900-kDa peak I was IgM, and peaks II-IV had H-positive material that perhaps corresponded to progressively smaller subunits (Fig.  1c) . Thus, hybridoma-derived anti-TNP IgM consisted of ϳ50% pentamer, with the rest H-L chain dimers and trimers, and possibly separate H and L chains.
The anti-TNP IgM pentamer 37.12 (FPLC Peak I) was tested for ability to reconstitute CS in TNP-Cl-sensitized B-1 cell-deficient xid mice. Fig. 1d shows that TNP-Cl-sensitized and -challenged xid mice did not elicit 2 and 24 h CS (group B), compared with vehicle immunized mice that were challenged on the ears similarly (group A). In contrast, 2 and 24 h CS was reconstituted when TNP-Cl immune xid mice received i.v. 100 g FPLC-purified anti-TNP IgM pentamer 1 day before challenge (group C). Thus, IgM pentamer likely was at least partially responsible for initiating elicitation of CS that led to local T cell recruitment. Surprisingly, fully reduced and alkylated anti-TNP IgM also mediated 2-h CS-initiating activity that reconstituted 24-h CS responses in xid recipients (group D), equivalent to or greater than those mediated by intact pentameric IgM (group C). In contrast, control nonspecific mouse myeloma IgM mediated neither 2-h swelling nor 24-h CS in PClsensitized and ear-challenged xid mice (group E). Thus, the CSinitiating activity of both intact IgM pentamer and fully reduced anti-TNP IgM was specific.
IgM H-L chain dimers, and separated H and L chains can also initiate CS
To identify which IgM subunits mediated CS initiation, we subjected intact IgM of hybridoma 13.4 (Fig. 2a, lane 1) to either mild reduction (0.25 mM DTT), which produced predominant dimers of joined H-L chains (lane 2) or to strong reduction (20 mM DTT), and then alkylation, resulting in separate H and L chains (lane 3) observed in nonreducing SDS-PAGE. Predominant pentamer restored 24 h CS in TNP-Cl sensitized xid mice at a total dose of 100 g or perhaps even 20 g i.v. per mouse (Fig. 2b , groups C and D). In addition, covalently linked H-L dimers mediated CS initiation at doses of 100 and 20 g per mouse (groups E and F). Surprisingly, even a mixture of separated H and L chains derived from this hybridoma 32.17 mediated CS initiation, also at doses of 100 and 20 g per mouse (groups G and H). We concluded that IgM pentamer, dimers of H and L chains, and even a mixture of separated H and L chains, all could initiate CS. Mildly reduced IgM contained a small amount of monomeric subunit (H 2 -L 2 ) that could have contributed to activity, but pentamer could not have contributed, since fully reduced IgM with strong CS-initiating activity (Fig. 1d, group D, and Fig. 2b , groups G and H) contained no pentamer.
Anti-TNP IgM subunits bind hapten in vitro
CS initiation by IgM subunits was unusual, so we tested if subunits could bind hapten, since CS initiation is hapten-specific (1, 2, 12). 4 Using another IgM hybridoma (FH-6) of different Ag specificity, we used a sensitive flow cytometry assay to detect binding of this anti-sialyl-Lex monoclonal IgM and its subunits to the carbohydrate hapten sialyl-LeX that is expressed on the surface of HL-60 cells. Fig. 3a shows the pentameric monoclonal IgM of FH-6 bound stronger than its derived IgM subunits at 10 g/ml. With dilution, the last detectable binding concentration of pentamer was 0.01 g/ml (Fig. 3a, top) , while predominant H-L dimers bound at 10 and 1.0 g/ml, but barely at 0.1 g/ml; i.e., 10 -20% binding compared with pentamer (Fig. 3a, middle) . Finally, separated IgM H and L chains had less binding at 10 g/ml, and did not bind at 1.0 g/ml (Fig. 3a, bottom) ; i.e., 3% compared with pentamer.
These findings were confirmed with a second assay using CSinitiating anti-TNP IgM mAb 13.4 binding to ELISA wells coated with different concentrations of TNP-BSA. Intact anti-TNP IgM at 2.0 g/ml bound strongly to TNP-BSA (Fig. 3b, F ) compared with BSA (E). Furthermore, H-L dimers had much less binding, requiring 100-1000 g/ml (f) that was significant vs binding to BSA (Ⅺ). In fact, even separated H and L chains had detectable but less binding to TNP-BSA over this range (OE) that still was significant compared with BSA (‚). We concluded that using two different IgM mAb with two different Ag specifities and two different binding assays, one using the CS-initiating anti-TNP IgM mAb (Figs.   FIGURE 1 . a, Size exclusion gel filtration purification of anti-TNP IgM pentamer. TNP affinity column-enriched anti-TNP IgM mAb from hybridoma 32.17 supernatant was run on Superose 6 FPLC column chromatography, resulting in 98% pure IgM pentamer in peak I. b, SDS-PAGE of Superose 6 gel-filtered FPLC peaks of 32.17 IgM. Samples were run on a 5% gel (range of 100-1000 kDa) under nonreducing conditions. Lane A, The TNP affinity-purified starting IgM material from the 32.17 anti-TNP IgM hybridoma contained predominantly IgM pentamer (900 kDa), two prominent bands at 130 and 160 kDa possibly representing H-L 2 trimer and H-H dimer, respectively, and L chain dimers and trimers, and also a band at ϳ106 kDa, likely representing isolated H-L dimer. FPLC gel filtration peak I was shown in lane B to consist of virtually pure IgM pentamer (900 kDa), while peak II (lane C) was a mixture of IgM pentamer and trimer of H-L 2 , and peak III (lane D) consisted of H-H dimer at 160 kDa, and smaller amounts of H-L 2 trimer and H-L dimer. Free H and L chains ran off this gel and thus could not be visualized. c, IgM H chain-specific ELISA of Superose 6 fractions. An ELISA specific for 32.17 IgM H chain was used to quantitate the amount of H chain in Superose 6 fractions from FPLC chromatography of TNP affinity-purified anti-TNP IgM mAb 32.17. Peak I contained the greatest amount (98%) of total of H chain antigenic activity, verifying the IgM pentamer in peak I and peaks II-IV had progressively less H chain. d, Reconstitution of CS in xid mice with pure pentameric anti-TNP IgM. IgM pentamer (FPLC peak 1) was tested for its ability to reconstitute CS (group C). In contrast, group B were TNP-Cl (PCl)-sensitized xid mice that were reconstituted with saline, while group C shows that the IgM pentamer (peak I) significantly reconstituted CS elicitation in PCl (TNP-Cl)-sensitized xid mice that were ear challenged with PCl (TNP-Cl), and group E shows that nonspecific IgM was inactive. Group D shows that strongly reduced and alkylated IgM also was active. Statistics: 2 h, group C or group D vs group B, p Ͻ 0.01 (ANOVA p Ͻ 0.001); 24 h, group C vs group B, p Ͻ 0.05 (ANOVA p Ͻ 0.05), and group D vs group B, p Ͻ 0.01 (ANOVA p Ͻ 0.002).
2b and 3b), showed that IgM subunits significantly bound hapten, but less than pentamer. This could account in part for ability of IgM subunits to mediate CS initiation (Fig. 2b) .
IgM and H-L dimers activate C, but separated H and L chains do not
CS initiation by IgM requires C activation for local generation of C5a to recruit T cells (1, 2, 8) . We tested whether subunits of anti-sialyl-LeX FH-6 IgM that weakly bound hapten could then activate C. Fig. 3c shows a modification of the hapten-cell flow cytometry assay, with initial incubation of intact IgM or its subunits with HL-60 cells, then addition of diluted fresh human serum, and then detection of bound C3b by using biotin-conjugated anti-human C3b Ab by adding PE streptavidin. Binding of IgM pentamer at 10 and 1.0 g/ml enabled strong activation of C, but 0.1 g/ml and 0.01 g/ml IgM activated C much less (Fig. 3c,  top) . IgM H-L dimers also activated C at 10 g/ml, less so at 1.0 g/ml, and just barely at 0.1 g/ml (Fig. 3c, middle) ; i.e., C activation ϳ25% compared with IgM pentamer. In contrast, separated IgM H and L chains that weakly bound hapten (Fig. 3, a and  b) could not activate C (Fig. 3c, bottom) . We concluded that compared with intact pentamer, subunits of IgM consisting of H-L dimers had less but significant ability to bind hapten and activate C, which might account for ability to mediate CS initiation. In contrast, separated H and L chains bound hapten very weakly and could not activate C. Thus, C activation could not be responsible for the ability of separated H and L chains to mediate CS initiation, since they weakly bound hapten and could not activate C.
IgM subunits from lymphoid cells of actively TNP-Cl sensitized mice also initiate elicitation of CS
Pentameric anti-TNP IgM and subunits derived from established hybridomas initiated CS. However, the smallest subunits of separated H and L chains bound Ag weakly and could not activate C, but still initiated CS. This was puzzling and raised questions about the relevance of using hybridoma-derived Ag-specific mAb compared with the physiological situation in vivo. Therefore, we attempted to obtain CS-initiating anti-TNP IgM material derived in vivo by generating culture supernatants from mixed lymph node and spleen cells of TNP-Cl contact-sensitized mice, and then partially purifying TNP-binding material on a TNP hapten affinity column. We used 1-day TNP-Cl immune cells that mediate CS initiation (16) 4 that likely is due to release of IgM by a small subpopulation of sensitized B-1 cells. 4 Previously, this TNP-Clinduced partially purified anti-TNP preparation was referred to as PCl factor or PCl-F (10 -12).
The purified in vivo-derived anti-TNP material was reduced, then after SDS-PAGE was tested via Western blot probed with anti-, anti-, and anti-chain Ab under reduced and nonreduced conditions. Anti-Ab probe of TNP-Cl immune anti-TNP IgM revealed IgM H chain corresponding to 80 kDa and an additional smaller band corresponding to 66 kDa under reducing conditions, which likely is deglycosylated H chain in the anti-TNP material, but no pentamer or H-L dimers could be seen (Fig. 4a, lane 2) . Furthermore, probing with anti-and anti-Ab showed that anti-TNP material contained L chain but not L chain (lanes 5 and  8) . Surprisingly, analysis under nonreducing conditions also revealed that in vivo-derived anti-TNP material that bound to and eluted from TNP affinity column also contained some free and chains in addition to expected IgM pentamer (lanes 3 and 6) . This suggests that anti-TNP and chains exist in vivo in TNP-Cl immune mice. In contrast, lanes 1, 4, and 7 show a positive control mouse myeloma IgM stained with anti-, anti-, and anti-. Notably, when the reduced anti-TNP material was injected i.v. at a dose of 100 g per mouse into previously TNP-Cl-sensitized xid mice, there was small but significant 2-h ear swelling elicited by TNP-Cl ear challenge (Fig. 4b, group E, left) , and importantly, this 2-h response led to strong reconstitution of 24-h CS (Fig. 4b, group  E, right) . We concluded that anti-TNP IgM subunits derived from 1-day PCl immune lymphoid cells had CS-initiating activity, like subunits of hybridoma-derived anti-TNP IgM mAb. Hapten affinity-purified anti-TNP IgM 13.4 was mildly (0.25 mM DTT) or strongly (20 mM DTT) reduced, followed by alkylation and then run on a 3-10% gradient gel, and compared with intact IgM pentamer. Lane 1, Intact IgM pentamer consisting of very high molecular mass (Ͼ200 kDa) pentamer, and some IgM monomer at Ϯ190 kDa. Lane 2, Mild reduction resulted in predominant H-L chain dimer at ϳ110 kDa, with a small amount of IgM monomer at ϳ200 kDa. There also was H-H dimer fragment at 160 kDa; and lane 3 shows that strong reduction resulted in a prominent 66-kDa band of H chain with reduced molecular mass likely due to deglycosylation, plus separated L chain doublet at ϳ25 kDa. 
Anti-TNP L chain-induced 2-h responses reconstitute 24-h CS in TNP-Cl-sensitized xid mice
TNP affinity-enriched IgM subunits resulting from strong reduction and alkylation were purified further, and isolated L chains but not H chains (16) were found to mediate 2-h ear swelling responses (Fig. 5a, group D) . To test whether the 2-h activity of anti-TNP L chains could initiate CS, we used two anti-TNP L chain preparations; native purified monoclonal anti-TNP chain and a recombinant anti-TNP L chain. Recombinant murine anti-TNP L chain cloned in E. coli (13) was expressed as a GST fusion protein. We tested if the two anti-TNP L chain preparations could reconstitute CS in PCl-sensitized xid mice. As before, positive control immunized CBA/J mice elicited strong 2-h initiating and 24-h effector phases of CS on day 4 (Fig. 5a, group A) , while similarly immunized and tested xid males elicited neither 2-nor 24-h responses (group B). In contrast, monoclonal anti-TNP L chains, given i.v. to TNP-Cl-sensitized xid mice 1 day before challenge on day 3 enabled elicitation of 2-h ear swelling 1 day later that resulted in reconstitution of 24-h CS responses (group D), likely due to recruited intact xid-derived CS-effector T cells induced by prior immunization with TNP-Cl. 4 Of great importance, recombinant anti-TNP L chain (5 g) similarly reconstituted CS in TNP-Cl-immunized and -challenged xid mice (group E). This was not due to contaminating GST, which was inactive (group C). We concluded that both purified polyclonal and recombinant monoclonal anti-TNP L chains can initiate CS.
Isolated anti-TNP L chains mediate C-independent 2-h ear swelling responses
We have shown previously that the 2-h ear swelling response is dependent on C activation (1, 2, 8) . Therefore, we determined whether the 2-h ear swelling activity of anti-TNP L chains involved activation of C. We used anti-C5 mAb treatment as a Cdepleting agent (1), and found that 2-h responses induced by anti-TNP L chain (Fig. 5b, group D) were not inhibited (group F) compared with recipients treated with isotype control mAb (group E). In contrast, positive control 2-h responses in 1-day TNP-Cl active immune mice were strongly inhibited by anti-C5 mAb (group C), but not by the isotype control (group B).
We used another C-affecting procedure, use of genetically C5-deficient mice (8) , and found that anti-TNP L chain-induced 2-h ear swelling was equivalent in C5-intact DBA/1 compared with C5-deficient DBA/2 mice (Fig. 5c, group C vs D) . In contrast, responses of 1-day TNP-Cl immune mice were reduced significantly in C5-deficient compared with C5-intact mice (group A vs B). We concluded that 2-h ear swelling mediated by L chain was C-independent, corroborating the in vitro results (Fig. 3c, bottom) .
Isolated L chain-dependent 2-h responses are mast celldependent, and consequent CS initiation is B cell-independent
Previous studies showed that 2-h swelling responses in actively TNP-Cl-sensitized mice and CS responses to anti-TNP L chains depend on activation of local mast cells (13) . Thus, we tested whether L chain-induced 2-h responses were mast cell-dependent. As expected, responses in 1-day TNP-Cl active immune mice were mast cell-dependent (Fig. 5d, group C vs D) . Furthermore, injection of anti-TNP L chains did not result in the ability to elicit the 2-h responses in these WBB6F1/J-Kit w
/Kit
w-v mast cell-deficient mice (groups E vs F). Therefore, direct C-independent mast cell activation likely accounts for the 2-h ear swelling activity induced by anti-TNP L chains. This established a pathway that was alternative to indirect mast cell triggering in CS via the C cascade following mast cell stimulation through the C5a receptor (2, 17) . The latter occurs in actively TNP-Cl-sensitized mice, most likely via anti-TNP IgM pentamers derived from B-1 cells. 4 To determine whether anti-TNP-specific L chains could provide CS-initiating early mast cell activation in the absence of other B cell-derived signals, we studied anti-TNP L chains in CS reactions of B cell-deficient MT mice. As previously reported (1), TNP-Cl-sensitized pan B cell-deficient mice, that in this case received PBS i.v. as control, were not capable of developing immune inflammatory 24-h CS ear-swelling responses when challenged with the sensitizing hapten (Fig. 6) 
Discussion
Prior studies on CS initiation showed that immune B-1 cells, via their secreted IgM Ab, are required for early events needed to elicit CS responses in mice (1, 2) . 4 We now describe in vivo function of biochemically characterized IgM pentamer and subunits that also initiate elicitation of Ag-specific CS response, i.e., the molecular events that are required for local recruitment of CS-effector T cells. We found that pentameric anti-TNP-specific IgM and its subunits, including mere L chains, can initiate CS. Thus, using B-1 celldeficient xid mice, we show that anti-TNP-specific L chains derived from either hybridoma IgM or generated from TNP-immunized mice, or via recombinant techniques, can reconstitute the elicitation of defective CS responses. Interestingly, although past experiments found that CS initiation was dependent on C generation of C5a (2), the early ear swelling reactions and CS initiation mediated by isolated anti-TNP chains were found to be C-independent. This perhaps is due to direct binding of the chains to mast cells via a postulated receptor for L chains, enabling subsequent activation by added Ag. Indeed, cross-linking of cell surface proteins of primary cultured mast cells via added L chains results in degranulation and lipid mediator production (13) .
We showed previously that pan B cell-deficient MT and JhD Ϫ/Ϫ mice had impaired CS ear swelling responses and absent local elaboration of IFN-␥, the crucial cytokine produced by recruited CS-effector T cells in these Th1 responses (1, 2) . 4 This suggested that B cells and perhaps Igs could be directly or indirectly involved in elicitation of these classical in vivo T cell-mediated CS responses. We also showed that predominantly B-1 celldeficient xid mice that have no serum IgM also exhibit poor CS responses. 4 Reconstitution of the xid mice or the JhD Ϫ/Ϫ mice with B-1 cells from TNP-immune mice injected just before challenge restored elicitation of CS responses in an Ag-specific manner. 4 Because B-1 cells are major producers of IgM (9), we postulated that anti-TNP-specific IgM produced by the B-1 cells might play a role in CS initiation. This was confirmed by reconstitution of CS in immunized xid mice by transfer of hybridoma anti-TNP IgM Ab. 4 However, we could not rule out the possibility that other active mediators released by B-1 cells in vivo could also mediate this activity. We now show that highly purified preparations of pentameric anti-TNP IgM indeed are able to reconstitute CS in xid mice, but in addition, even IgM subunits can induce CS initiation. However, it is unlikely that the doses we used of 100 g IgM or subunits reflect the actual amount needed in vivo in actively sensitized mice, since as little as 0.7 ml of 1-day immune sera suffices, 4 and there may be other factors produced in vivo that boost the CS-initiating effect of the IgM Ab, resulting in less being required.
The mechanisms by which IgM could initiate CS responses are not fully understood. Thus, restoration of CS by B-1 cell-produced IgM Ab in immunized xid mice could be due to several mechanisms. Pentameric IgM can activate the classical C pathway resulting in generation of C component fragments, such as C3a and C5a that could, especially C5a, directly activate local microvessels (17, 18) to enable T cell recruitment (5) . Indeed, we found that there is elaboration of C5a at the local site within 1 h of challenge (2) , and that CS responses are absent in C5 (8) and C5a receptordeficient mice (2) . Alternatively, C fragments like C5a could lead to vascular activation indirectly by binding C5aRs (17, 18) , thereby degranulating mast cells (19) and platelets (20) , resulting in release of vasoactive mediators like TNF-␣ (2, 5) and serotonin (3) that are required to activate microvessels for the T cell recruitment (5). Mast cell-derived TNF-␣ also could play a role in T cell recruitment via the induction of chemokines (15) . Either a direct vascular activation pathway or indirect vascular activation via mast cell and platelet mediators would lead to release of TNF-␣ and serotonin to increase vascular permeability and crucial expression of endothelial adhesion molecules such as ICAM-1 and VCAM-1 (5). This would allow local luminal binding and extravasation of Ag-specific CS-effector T cells into the tissues to thus initiate CS responses. This would be followed by T cell activation on APC in the extravascular tissues for production of proinflammatory IFN-␥ and local induction of chemokines like IP-10 at the 24-h CS site (1, 2) . 4 Notably, the anti-TNP IgM Ab mainly is circulating and is located mainly in the intravascular space, raising the question of how the IgM binds the Ag to elicit responses. In elicitation of CS, locally dispersed hapten bound to self Ag may penetrate the intravascular space to enable binding to IgM. How IgM might get into the tissues is still an open question, but we speculate that nonspecific irritation caused during Ag challenge may alter the permeability of local vessels, allowing circulating IgM to leak into the tissues and thus bind Ag to begin CS initiation, or L chain activity initiates IgM transit into the tissues.
It has been shown previously that separation of Ig H and L chains by reduction of interchain disulfide bonds decreased C activation by 90% (21) . In this study, we also observed that fully separated H and L chains of IgM did not activate C (Fig. 3c) . However, mildly reduced IgM that contained H-L dimers, and thus had some of the remaining crucial interchain disulfide bonds, exhibited ϳ25% C activation compared with intact IgM pentamer molecules (Fig. 3c) . Another study on the importance of interchain disulfide bonds showed that separated and noncovalently reassembled IgG-derived H ϩ L chains were devoid of ability to bind the first C component, C1 (22) , whereas IgG-derived covalently linked H ϩ L dimers were as active as the intact parent IgG. Thus, these prior studies, as well as our current observations, stress the requirement for interchain disulfide bonds for binding and activation of C. However, we did not find any correlation between the in vitro C-activating ability of H-L dimers, or separated H and L chains with ability to reconstitute CS ear swelling responses, since all the subunits were equally active (Fig. 2b) . Therefore, we propose that initiation of CS by H-L dimers and by separated H and L chains that actually turned out to be mediated by chains alone may thus occur via a C-independent mechanism.
Another prior study compared the binding of C1q to pentameric IgM, or to monomeric H 2 -L 2 subunits of IgM, or to intact H 2 -L 2 of IgG Ab specific for the same hapten Ag, which was fluorescein (23) . Interestingly, these investigators observed that the C1q-binding ability of the IgM monomer H 2 -L 2 subunit was similar to that of ␥ 2 -L 2 IgG. In other words, when the pentameric IgM is reduced to the monomeric H 2 -L 2 subunit, and binds the fluorescein hapten, it behaved much like a bivalent IgG Ab in its ability to bind C1q, and then activate C. It was concluded that the superior binding of C to intact IgM pentamer relative to the monomeric H 2 -L 2 subunit, or to similar H 2 -L 2 IgG, was related to the polymeric structure and multiple active binding sites of IgM Fc portions for binding C1q, rather than to structural or affinity differences between the two hapten-binding Ig isotypes, i.e., IgM or IgG. In the current study, we observed that monomeric H 2 -L 2 IgM subunits had ϳ25% Cbinding capacity compared with intact IgM pentamer. In view of the observations above concerning binding of fluorescein (23), this is not surprising since our data suggest that one can expect only ϳ20% C activation by IgM H 2 -L 2 monomer compared with intact IgM pentamer.
This study is the first to show that fully separated L and H chains also can initiate CS, and that this may proceed by yet another, and C-independent, mechanism. We propose that separated L chains, exclusive of H chains, may act directly by binding to postulated receptors on mast cells (11, 13, 14, 24) , since L chain-mediated CS initiation was shown in this study (Fig. 5, b and c) to be C-independent while being mast cell-dependent (Fig. 5d) . Thus, in accord with a prior study (13) , our data demonstrate mast cell dependency of CS initiation via L chains. Cross-linking of L chains bound to these putative mast cell receptors leads to activation of mast cells (13) , resulting in release of vasoactive mediators required for T cell recruitment. A similar receptor was proposed previously for mast cell sensitizing material in a TNP-specific factor called PCl-F that was derived from culture supernatants of lymphoid cells of TNP-Cl contact-sensitized mice. Indeed, this PCl-F was absorbed out by in vitro incubation with purified mast cells (14, 19 ). In the current study, TNP-Cl CS was used to induce similar in vivoderived TNP-binding material that was shown to initiate CS (Fig.  4b) . Thus, mast cells may be involved in CS initiation via two different pathways. One may be an indirect mast cell-activating process via pentameric IgM and some subunits activating C to generate bioactive peptides like C5a to lead to vascular activation indirectly via stimulating release of mast cell and platelet mediators. In contrast, the other pathway for CS initiation activates mast cells directly via IgM-derived L chains binding to mast cell receptors via Ag, and activating mast cell release of vasoactive mediators independent of C.
Because anti-TNP IgM or its subunits obtained from hybridomas that also mediated CS initiation may not be representative of what is present in vivo, we produced in vivo-derived anti-TNP IgM subunits by TNP-Cl skin contact-sensitizing mice and then harvesting 1-day immune lymphoid cell supernatants. As noted, originally such material that can initiate CS was described as PCl-F (10 -12, 14, 19, 24) , but was poorly characterized. This PCl-F seemed to initiate CS via mast cell activation and partial degranulation (19) . An important characteristic of PCl-F was ability to initiate CS even after reduction of disulfide bonds followed by alkylation (10 -12) . This suggested that interchain or intrachain disulfide bonds in PCl-F may not be essential for CS initiation. The current study shows that subunits of anti-TNP IgM even are released directly from in vitro cultured hybridomas, or via reduction and alkylation of intact pentamers, and can initiate CS-like PCl-F. This new finding that anti-TNP IgM subunits can reconstitute CS in immune xid mice prompted us to investigate further the relationship between the poorly characterized PCl-F and anti-TNP IgM Ab subunits that both can mediate CS initiation.
We postulated that subunits of anti-TNP IgM might have been present in the in vivo-derived PCl-F preparation, and may have been involved in CS initiation. Indeed, immunoblotting of hapten affinity purified in vivo-derived PCl-F that was run under nonreducing conditions and stained with anti-anti--specific Ab showed remarkably that even unreduced native PCl-F contained determinants of free IgM H chain and L chain (Fig. 4a, lanes 3  and 6) . Therefore, PCl-F derived from supernatants of lymphoid cells from contact-sensitized mice likely contains anti-TNP IgM subunits produced in vivo by lymph node and spleen B cells only 1 day following contact sensitization. One possibility, albeit very small, that we cannot rule out, is that these anti-TNP IgM subunits were generated via in vitro processing of the in vivo-derived IgM pentameric material produced by 1-day immune cells. Notably, these 1-day immune cells are able to transfer CS initiation (16), 4 as does 1-day immune sera that likely contains B-1 cell-derived immune IgM. 4 In fact, prior studies also have shown that PCl-F contained smaller size molecules (30 -50 kDa) (10, 11) that can mediate early ear swelling that at the time were not thought of as derived from B-1 cell IgM. This finding now suggests that even smaller subunits of IgM contained in PCl-F may be involved in CS initiation. Indeed, in this study, we found that anti-TNP material obtained from 1-day immune cells contained free IgM H chains and L chains (Fig. 4a, lanes 3 and 6) . Thus, we now have shown that fully reduced IgM that was derived from an anti-TNP hybridoma or from this in vivo-derived PCl-F that was reduced and alkylated are both able to reconstitute CS. This allowed elicitation of both 2-and 24-h components of CS in sensitized xid mice that provided the recruited CS-effector T cells (Figs. 2b and 4b) . Therefore, as suggested by immunoblot analysis, anti-TNP IgM subunits possibly present in vivo and similar to those derived in vitro from IgM-producing hybridomas may have the ability to initiate CS. This is consistent, since the presence of in vivo circulating L chains has been reported previously in several instances. Thus, concentrations of circulating Ig L chains have been associated with some clinical disorders of the immune system, such as multiple sclerosis (25, 26 ), Sjorgen's Syndrome (27) , systemic lupus erythematosus (28), chronic lymphocytic leukemia (29) , and in normal patients and in those with kidney disease (30) . Reports of abnormal synthesis of Igs by hybridomas also suggest that H chains normally are not secreted by plasma cells; they accumulate and cause plasma cells to die off, while L chains alone can be synthesized and secreted by some mouse myeloma cell lines (31) . We also observed the presence of H and L chains in the anti-TNP IgM hybridoma supernatants in this study. In another instance, an H ϩ B cell lymphoma that did not secrete IgM still was able to secrete H chains (31, 32) . Thus, putting these prior observations together, our proposal that anti-TNP IgM subunits could be produced in vivo is plausible. Studies are in progress to further characterize such in vivo-derived Ig subunits in contact-sensitized mice.
The most direct evidence that separated IgM subunit chains have CS-initiating ability was demonstration that recombinant monoclonal anti-TNP L chain alone, like purified monoclonal anti-TNP L chain, could transfer 2-h ear swelling activity that mediated CS initiation, both in pan B cell-deficient MT mice (Fig. 6 ) and in B-1 cell-deficient xid mice (Fig. 5) . The reconstitution of CS in MT mice with L chains rules out the possibility that endogenous Ig chains such as H chains could have combined in vivo with the transferred L chain to mediate CS-initiating activity. Although reconstitution of MT mice with purified TNP-specific L chain restores CS, we cannot rule out the possibility that transferred isolated chains may associate with non-Ig molecules in vivo to exert the CS-initiating activity. In contrast to CS initiation by anti-TNP IgM pentamer present in 1-day immune actively sensitized mice, the CS-initiating activity of TNP-specific L chains appears to be mediated independent of C. Accordingly, mice treated with anti-C5 or C5-deficient mice did not have decreased 2-h CS responses mediated by L chain compared with responses in 1-day immune mice that were inhibited by anti-C5 and by C5 deficiency, and thus, were C-dependent, presumably due to dependence on intact IgM (Fig. 5, b and c) . Additionally and in contrast, since anti-TNP L chain-mediated 2-h CS responses like those in 1-day immune mice were absent in mice that lack mast cells (Fig. 5d, group F) , we propose that the isolated L chains act directly on mast cells, possibly by binding to a putative receptor, followed likely by cross-linking with multivalent challenge TNP-self Ag, and thus release vasoactive mediators needed for local recruitment of T cells (13) .
In summary, we show for the first time that IgM Ab and its subunits likely derived from B-1 cells early after immunization are involved in the initiation of T cell-mediated CS responses. Furthermore, we propose that initiation of CS responses that leads to the local recruitment of CS-effector T cells can occur via at least two Ag-specific pathways (33) . The first is C-dependent via IgM pentamer that activates C to generate fragments like C5a to trigger mast cell release of vasoactive mediators indirectly. The second is C-independent, via smaller IgM subunits such as L chains, that directly lead to mast cell activation for T cell recruitment. Having such different and redundant pathways makes sense physiologically to guarantee the mediation of such a critical and essential T cell recruitment step in vivo for effector T cell-mediated immune responses.
